Charles River Laboratories International Inc.
01/22/2025 | News release | Distributed by Public on 01/22/2025 10:59
CNS Drug Discovery and Design Made Smarter
In a recent agreement made with Lundbeck, they will now have access to Logica®, Charles River and Valo Health's AI platform, to help progress their research into disorders of the nervous system.
Using industry-leading predictive models, chemical design, and synthetic capabilities, Logica's integrated, AI-augmented process translates biological insights into optimized preclinical candidates while reducing the use of research animals.
Through this agreement, Lundbeck will deploy Logica with the aim of creating optimized small molecules that lead to novel therapies for neurological research.
Charles River Laboratories International Inc. published this content on January 22, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 22, 2025 at 16:59 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io